In detection of aberrantly methylated DNA in plasma samples, Lofton-Day et al. identified three blood-based molecular biomarkers including TMEFF2, NGFR, and SEPT9 that were useful for CRC screening 11. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.